Targeted Protein Degradation for Drug Discovery

06:06 EDT 7 Aug 2019 | Lab Bulletin

Targeted-Protein-Degradation-for-Drug-DiscoveryAMSBIO has introduced a new range of homogeneous proximity assays, critical enzymes and small molecule inhibitors to assess the chemical adaptor function of Proteolysis Targeting Chimeras (PROTACs). Targeted protein degradation using PROTACs is a new and promising therapeutic method in drug discovery....

Original Article: Targeted Protein Degradation for Drug Discovery


More From BioPortfolio on "Targeted Protein Degradation for Drug Discovery"

Quick Search

Relevant Topics

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...